Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer

20 Feb 2014

Abstract excerpt

Cyclin-dependent kinase inhibitor 3 (CDKN3) has been reported to promote tumor genesis. Since it is unclear whether CDKN3 participates in the development of epithelial ovarian cancer (EOC), this study assessed the association between CDKN3 expression and cell biological functions, and demonstrated the clinical significance and prognosis of CDKN3 in EOC. CDKN3 expression was evaluated in 97 cases of tumor tissue...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Cancer Mechanisms and Therapy
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24573179
DOI: 10.3892/or.2014.3045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancerPMID 24573179Read ↗

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinomaSemantic proximity Read ↗

Human pan-cancer analysis of the predictive biomarker for the CDKN3Semantic proximity Read ↗

Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell CarcinomaSemantic proximity Read ↗

Human pan-cancer analysis of the predictive biomarker for the CDKN3Semantic proximity Read ↗

CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinomaSemantic proximity Read ↗

CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical CancerSemantic proximity Read ↗

RSPO3 is a marker candidate for predicting tumor aggressiveness in ovarian cancerSemantic proximity Read ↗

Targeting<i>CDKN3</i>in cervical cancerSemantic proximity Read ↗

microRNA-324-3p suppresses the aggressive ovarian cancer by targeting WNK2/RAS pathwaySemantic proximity Read ↗

miR-93-5p Suppresses Ovarian Cancer Malignancy and Negatively Regulate CCND2 By Binding To Its 3’UTR RegionSemantic proximity Read ↗

FHOD3 shows clinical significance in progression of ovarian cancer through regulation of caspase-3 signaling pathwaySemantic proximity Read ↗

PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.